- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Topical antibiotics use in pediatric acute infective conjunctivitis has favorable outcomes: JAMA
Using topical antibiotics for acute infective conjunctivitis in pediatric patients has shown favorable outcomes as per a recent study that was published in the journal JAMA Network Open.
There is uncertainty regarding the use of antibiotics for acute infective conjunctivitis in children. Hence researchers from Finland conducted a randomized clinical trial to assess the efficacy of topical antibiotic therapy for acute infective conjunctivitis. The study was carried out at primary health care in Oulu, Finland, from October 15, 2014, to February 7, 2020. Children aged 6 months to 7 years with acute infective conjunctivitis were taken as participants in the study and followed up for 14 days. Participants were randomized to moxifloxacin eye drops, placebo eye drops, or no intervention. The primary outcome of the randomized clinical trial was time to clinical cure in days.
A subsequent meta-analysis was done including the present trial and 3 previous randomized clinical trials enrolling pediatric patients aged 1 month to 18 years with acute infective conjunctivitis. The primary outcome of the meta-analysis was the proportion of participants with conjunctival symptoms on days 3 to 6.
Results:
- The randomized clinical trial included 88 participants including 46 girls.
- They were randomized to 3 groups of 30 patients with a mean age of 2.8 years to moxifloxacin eye drops, 27 children with a mean age of 3 years to placebo eye drops, and 31 participants with a mean age of 3.2 years who did not receive any intervention.
- The time to clinical cure was significantly shorter in the moxifloxacin eye drop group than in the no-intervention group (3.8 vs 5.7 days).
- In the survival analysis, both moxifloxacin and placebo eye drops significantly shortened the time to clinical cure relative to no intervention.
In the meta-analysis, a total of 584 children were randomized with 300 to topical antibiotics and 284 to a placebo, and the use of topical antibiotics was associated with a significant reduction in the proportion of children who had symptoms of conjunctivitis on days 3 to 6 compared with placebo eye drops.
Thus, in this randomized clinical trial and systematic review and meta-analysis, the use of antibiotic eye drops was associated with significantly shorter durations of symptoms in children with conjunctivitis, often called pink eye.
Further reading: 10.1001/jamanetworkopen.2022.34459
Honkila M, Koskela U, Kontiokari T, et al. Effect of Topical Antibiotics on Duration of Acute Infective Conjunctivitis in Children: A Randomized Clinical Trial and a Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(10):e2234459
BDS, MDS
Dr.Niharika Harsha B (BDS,MDS) completed her BDS from Govt Dental College, Hyderabad and MDS from Dr.NTR University of health sciences(Now Kaloji Rao University). She has 4 years of private dental practice and worked for 2 years as Consultant Oral Radiologist at a Dental Imaging Centre in Hyderabad. She worked as Research Assistant and scientific writer in the development of Oral Anti cancer screening device with her seniors. She has a deep intriguing wish in writing highly engaging, captivating and informative medical content for a wider audience. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751